28
Aug 2026
New discovery paves way for highly personalized breast cancer therapies
MYC is a common oncogene that regulates tumor growth and spread, yet no approved drugs exist to target it.
Stay Informed!
28
Aug 2026
Philosophical study redefines moral distress in modern healthcare systems
Nurses and physicians often recognize what kind of care a patient deserves in a given moment, be it more time at the bedside, a change in pain management, or a detailed conversation about the goals of a specific treatment.
28
Aug 2026
Aficamten improves symptom burden and exercise capacity in patients with non-obstructive HCM
Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with symptomatic non-obstructive hypertrophic cardiomyopathy, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.
28
Aug 2026
POET-II trial reduces antibiotic duration for infective endocarditis by two weeks
A response-tailored strategy reduced antibiotic duration by two weeks without compromising the safety of patients with left-sided infective endocarditis.
28
Aug 2026
Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk
Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the SINGLE-AF trial presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.
28
Aug 2026
Younger heart patients benefit from implantable cardioverter-defibrillators in CMR GUIDE trial
An implantable cardioverter-defibrillator did not improve the primary endpoint overall in the CMR GUIDE trial but younger patients appeared to benefit, according to results presented in a Hot Line session today at ESC Congress 2026 and published simultaneously in JAMA.
28
Aug 2026
Rapid rise of GLP-1 medicines brings obesity and eating disorders together
Obesity and eating disorders have traditionally been treated as separate areas of healthcare – but the rapid rise of GLP-1 medicines is increasingly bringing the two together.
28
Aug 2026
UCSF scientists build largest molecular interaction map for autism
For more than two decades, researchers have identified hundreds of genes that increase the risk of autism spectrum disorder (ASD).
28
Aug 2026
African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
Leading African biopharmaceutical company Minapharm Group (www.Minapharm.com), headquartered in Egypt with subsidiaries in Berlin, will receive up to US$16.5 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of a Bundibugyo ebolavirus vaccine candidate, strengthening efforts to develop vaccines to combat the fastest-growing and second-largest Ebola outbreak on record affecting the Democratic Republic of the Congo (DRC).
28
Aug 2026
CARDIO-TTRansform trial investigating eplontersen fails to meet primary efficacy endpoint
The CARDIO-TTRansform trial investigating eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy did not meet its primary efficacy endpoint, according to results presented in a Hot Line session today at ESC Congress 2026.
